lysergic acid diethylamide has been researched along with loxapine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glennon, RA | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Barlas, C; Mishra, RK; Saeedi, H; Singh, AN | 1 |
1 review(s) available for lysergic acid diethylamide and loxapine
Article | Year |
---|---|
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Topics: Animals; Humans; Ligands; Receptors, Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
2 other study(ies) available for lysergic acid diethylamide and loxapine
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Blood Platelets; Dopamine Antagonists; Dose-Response Relationship, Drug; Down-Regulation; Female; Follow-Up Studies; Humans; Loxapine; Lymphocytes; Lysergic Acid Diethylamide; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2003 |